Atlas Trials

Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes

Clinical trial NCT01602003 · COMPLETED

Trial details

NCT number
NCT01602003
Sponsor
LG Life Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2009-12-01
Primary completion
2011-06-01
Enrollment
425

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.